569 related articles for article (PubMed ID: 27714849)
1. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
[TBL] [Abstract][Full Text] [Related]
2. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
[TBL] [Abstract][Full Text] [Related]
3. Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.
Nagata T; Nakajima S; Shinagawa S; Plitman E; Nakayama K; Graff-Guerrero A; Mimura M
J Alzheimers Dis; 2017; 60(1):263-272. PubMed ID: 28800334
[TBL] [Abstract][Full Text] [Related]
4. Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.
Nagata T; Shinagawa S; Nakajima S; Mimura M; Shigeta M
J Alzheimers Dis; 2018; 66(1):139-148. PubMed ID: 30248052
[TBL] [Abstract][Full Text] [Related]
5. Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease.
Mohamed S; Rosenheck R; Lyketsos CG; Kaczynski R; Sultzer DL; Schneider LS
J Clin Psychiatry; 2012 Jan; 73(1):121-8. PubMed ID: 21939611
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
[TBL] [Abstract][Full Text] [Related]
7. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
Sultzer DL; Davis SM; Tariot PN; Dagerman KS; Lebowitz BD; Lyketsos CG; Rosenheck RA; Hsiao JK; Lieberman JA; Schneider LS;
Am J Psychiatry; 2008 Jul; 165(7):844-54. PubMed ID: 18519523
[TBL] [Abstract][Full Text] [Related]
8. Behavioural and psychological symptoms of dementia in patients with Alzheimer's disease and family caregiver burden: a path analysis.
Kim B; Noh GO; Kim K
BMC Geriatr; 2021 Mar; 21(1):160. PubMed ID: 33663416
[TBL] [Abstract][Full Text] [Related]
9. Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study.
Nagata T; Shinagawa S; Yoshida K; Noda Y; Shigeta M; Mimura M; Nakajima S
J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32074412
[TBL] [Abstract][Full Text] [Related]
10. Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation.
Miller EA; Schneider LS; Rosenheck RA
Int Psychogeriatr; 2011 Feb; 23(1):44-53. PubMed ID: 20214847
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of psychiatric function disorders in psychogeriatric patients at referral to nursing home care--the relation to cognition, activities of daily living and general details.
Bakker TJ; Duivenvoorden HJ; van der Lee J; Trijsburg RW
Dement Geriatr Cogn Disord; 2005; 20(4):215-24. PubMed ID: 16088137
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
Burke SL; Maramaldi P; Cadet T; Kukull W
Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
Delgado C; Vergara RC; Martínez M; Musa G; Henríquez F; Slachevsky A
J Alzheimers Dis; 2019; 67(1):381-392. PubMed ID: 30584142
[TBL] [Abstract][Full Text] [Related]
16. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
[TBL] [Abstract][Full Text] [Related]
17. Burden in caregivers of primary care patients with dementia: influence of neuropsychiatric symptoms according to disease stage (NeDEM project).
García-Martín V; de Hoyos-Alonso MC; Delgado-Puebla R; Ariza-Cardiel G; Del Cura-González I
BMC Geriatr; 2023 Aug; 23(1):525. PubMed ID: 37644410
[TBL] [Abstract][Full Text] [Related]
18. Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.
Devanand DP; Strickler JG; Huey ED; Crocco E; Forester BP; Husain MM; Vahia IV; Andrews H; Wall MM; Pelton GH
Contemp Clin Trials; 2018 Aug; 71():33-39. PubMed ID: 29859917
[TBL] [Abstract][Full Text] [Related]
19. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric symptoms and activities of daily living in Alzheimer's disease: ALSOVA 5-year follow-up study.
Saari T; Hallikainen I; Hintsa T; Koivisto AM
Int Psychogeriatr; 2020 Jun; 32(6):741-751. PubMed ID: 31656211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
